Basics |
Company: |
180 Life Sciences Corp. |
IPO Date: |
June 26, 2017 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$3.97M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.16 | 5.37%
|
Avg Daily Range (30 D): |
$0.04 | 2.99%
|
Avg Daily Range (90 D): |
$0.20 | 5.06%
|
Institutional Daily Volume |
Avg Daily Volume: |
.16M |
Avg Daily Volume (30 D): |
.11M |
Avg Daily Volume (90 D): |
1.26M |
Trade Size |
Avg Trade Size (Sh.): |
38 |
Avg Trade Size (Sh.) (30 D): |
231 |
Avg Trade Size (Sh.) (90 D): |
122 |
Institutional Trades |
Total Inst.Trades: |
22 |
Avg Inst. Trade: |
$.86M |
Avg Inst. Trade (30 D): |
$.64M |
Avg Inst. Trade (90 D): |
$.64M |
Avg Inst. Trade Volume: |
M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$.82M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
.39K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$7.98
|
$-.85
|
$.01
|
Diluted EPS
|
$7.98
|
$-.85
|
$.01
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -3.12M
|
$ -.84M
|
$ .01M
|
Operating Income / Loss
|
$ -6.37M
|
$ -.98M
|
$ -1.85M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ .24M
|
$ .25M
|
$ -.01M
|
PE Ratio
|
0.16
|
|
|
Splits |
Feb 28, 2024:
19:1
|
Dec 19, 2022:
20:1
|
|